RussianPatents.com

Method for applying wave action to pathogenic microorganisms, viruses and tumor cells in experiment. RU patent 2250788.

IPC classes for russian patent Method for applying wave action to pathogenic microorganisms, viruses and tumor cells in experiment. RU patent 2250788. (RU 2250788):

G09B23/28 - for medicine
A61N5 - Radiation therapy (devices or apparatus applicable to both therapy and diagnosis A61B0006000000; applying radioactive material to the body A61M0036000000)
Another patents in same IPC classes:
Method for experimental modeling urinary calculosis Method for experimental modeling urinary calculosis / 2248045
The present innovation deals with modeling urinary calculosis in rats due to injecting intraperitoneally 60%-glucose solution at 1 ml/100 g animal body weight twice daily for 2 mo. The method is very simple and enables to achieve lithogenesis in 25% experimental animals.
Method and device for studying transosseous osteosynthesis model stiffness Method and device for studying transosseous osteosynthesis model stiffness / 2246139
Method involves studying transverse longitudinal and rotation stiffness characteristics. The studies are carried out step-by-step from the first order units to complete external fixation apparatus structure. The device has frame and is provided with calibration loads, wire rope, displacement indicators, strip for fastening to loading end of bone imitator fragment, beam for fixing displacement indicators, beams having unit for modeling longitudinal and transverse loadings. The frame is manufactured as parallelepiped. The fixing panel has openings for bone imitator, for fixing external fixation apparatus and yoke connection union and is fixed in end face part of the frame. Beam for fixing displacement indicators has longitudinal slit for fixing the indicators and arranging them on lateral slots in frame base. The beams having unit for modeling rotational, longitudinal and transverse loadings are arranged on lateral frame sides on lateral slots in base.
Method for modeling acute pancreatitis Method for modeling acute pancreatitis / 2244345
As experimental animals one should apply mongrel dogs of 12-17 kg body weight. Under general anesthesia one should conduct superior-median laparotomy, introduce 3.0 ml 70%-ethanol solution under pancreatic capsule and then laparotomic wound should be sutured up. Manipulation should be performed once. The method provides modeling adequate acute pancreatic inflammation at no side effects being very simple in implementation.
Device for applying electromagnetic treatment to biological tissue Device for applying electromagnetic treatment to biological tissue / 2250119
Device has body having pulsating light sources inside with reflector, aperture, filters and light guide cable prism which greater side is turned towards the light guide cable. The light guide cable prism has materials allowing radiation to be amplified in given wavelength range. Light sources are arbitrarily arranged in space in the device body relative to each other. The reflectors have concave surfaces of the at least second order. The aperture is arranged in front or behind the filter. The prism is usable also as heat insulation or heat discharge unit. One of prism embodiments is manufactured from heavy flint glass, ruby, glass or quartz alloyed with materials allowing amplifying radiation in selected wavelength range. The second prism embodiment is light guide casing filled with fine alloy materials usable for amplifying radiation in given wavelength range placed in liquid having refraction coefficient corresponding to one of the fine alloy material applied. Luminescent materials are usable as the materials allowing radiation to be amplified in given wavelength range. Lateral surface of the prism has at least one reflecting coating. The device optionally has reflecting surfaces symmetrically arranged relative to vertical optical symmetry axis of the device between light source reflectors and aperture. The light sources allow combined or separate functioning mode.
Microwave applicator Microwave applicator / 2250118
Device has coaxial input for conducting microwave signal of given frequency, wave guide filled with dielectric a part of which projects from the wave-guide forming aerial tip. The coaxial input is has internal conductor passing along wave-guide axis to the aerial tip and ending in the wave-guide body. Lateral conductor projects from it in radial direction at the one half of the conductor length within the wave-guide boundaries.
Method and device for treating the cases of epilepsy Method and device for treating the cases of epilepsy / 2249471
Method involves concurrently treating brain with longitudinal and transverse electromagnetic fields caused by high frequency sinusoid signals having carrier frequencies belonging to 200-1000 kHz bandwidth amplitude-modulated with low frequency signals having continuously variable frequency in frequency bandwidth of 4-24 Hz. Treatment is applied by means of two action elements of transverse electromagnetic field bitemporally placed and one longitudinal electromagnetic field action element manufactured as resonance LC-contour. The device has power supply source, electromagnetic oscillation source and two action elements. The electromagnetic oscillation source is manufactured as active oscillator which carrier frequency belongs to 200-1000 kHz bandwidth.
Method and system for taking general skin care Method and system for taking general skin care / 2248823
Method involves checking skin state, giving massage treatment with infrared radiation in remote infrared spectrum zone being used, ozone massage, low frequency wave massage, low frequency vibration wave massage and ultrasonic massage, cleansing skin, giving skin care and introducing nutrients into the skin. Device has units for acting with low frequency waves, infrared radiation in remote infrared spectrum zone, low frequency vibration waves and ultrasound, cleansing skin, checking skin state, and working key unit, presentation unit, memory unit, power supply unit, unit for initiating skin cleaning and skin care.
Method for treating children and teenagers for scoliosis Method for treating children and teenagers for scoliosis / 2248822
Method involves exposing motor activity points of injured dorsal muscles to pulsating extremely high frequency noise radiation in bandwidth of 52-78 GHz, duration of 1 mcs, mean power flow intensity of 0.85 mcW/cm2. Their tonus is to be determined in advance. Tonus being initially high, the daily treatment session is 5-8 min long. Tonus being initially low, the daily treatment session is 2-4 min long. The total treatment course is 8-15 procedures long.
Method and device for treating the cases of subacute saplingo-oophorite Method and device for treating the cases of subacute saplingo-oophorite / 2248819
Method involves applying variable electromagnetic field excited by amplitude-modulated signal having carrier frequency in 100-1000 kHz bandwidth and modulating frequency in 10-8000 kHz bandwidth, and irradiation with low intensity quasi-monochromatic radiation of visible and proximal infrared wavelength bandwidth with small spectrum width. Two action elements are used when performing the treatment. The first one is vaginal action element having inductive transmitter of resonant type emitting electromagnetic oscillations with carrier frequency belonging to 100-1000 kHz bandwidth amplitude-modulated in 10-8000 kHz bandwidth and low intensity quasi-monochromatic radiation of visible and proximal infrared wavelength bandwidth with small spectrum width. The treatment is carried out concurrently and in continuous mode. The device has power supply source, sinusoid signal oscillator and vaginal action element having dielectric casing. The casing encloses inductive transmitter winding. The sinusoid signal oscillator has active oscillator with inductive transmitter winding being concurrently used as inductive element of oscillatory circuit of the active oscillator. Low frequency oscillator is additionally available. Its output is connected to active oscillator circuit via modulator. Control tract has in series connected amplitude detector, DC amplifier and indicating unit. An additional supracutaneous treatment element has active oscillator, inductive transmitter winding concurrently serving as active oscillator inductance element, modulator, which input is connected to low frequency oscillator output and its output is connected to active oscillator circuit. The control tract has in series connected amplitude detector, DC amplifier and indicating unit. M photodiodes are connected in series via timer and acoustic indication element.
Method for treating the cases of chronic generalized periodontitis of mild and moderate severity degree / 2248785
Method involves applying pharmacotherapy, taking Calcium Biophick and Complevit. Biologically active points and periodontium tissues are exposed to electromagnetic radiation of extremely high frequency. Noise electromagnetic radiation is used in bandwidth of 53.57-78.33 GHz and specific power of 1.0-4.0 mcW/cm2 with nonuniform noise spectrum frequency distribution no exceeding ±3 dB. First, biologically active point of He-Gu is treated on the right and left arm in turn during 5-7 min. Then, periodontium area is acted in transition fold projection on maxilla and mandible on vestibular side in turn in perpendicular to area under radiation treatment during 10-15 min. The total treatment course is 6-9 daily sessions long.
Method for determining initial density of laser radiation power in performing transpupillary diode laser thermotherapy of intraocular tumor / 2248773
Method involves producing ophthalmoscopic tumor image and visually estimating its pigmentation. Digital computer-assisted analysis of tumor image color parameters is carried out by applying Adobe Photoshop software. Digital 0 code is assigned to absolutely black color and digital code of 765 is assigned to absolutely white color. Transpupillary diode laser thermotherapy is started with color code of 153 to 289 beginning from power density of 4.2 W/cm2. Color code being of 290 to 503, the treatment begins with 7.8 W/cm2. Color code being of 504 to 635, the treatment begins with 11.4 W/cm2.
Apparatus for carrying out laser irradiation of blood Apparatus for carrying out laser irradiation of blood / 2248231
Device is applied for carrying out combined simultaneous blood irradiation at red light wavelength and infusion therapy with physiologic saline containing drugs supplied to the same point in patient vein via dropper. Needle of cocoon cross-section is used.
Device for treating aids virus infection Device for treating aids virus infection / 2248230
Device has monochrome pulsating radiation source, at least two uprights and at least two fans. Gas discharge lamp is used as radiation source. Five gas discharge lamps are arranged in arrow on each upright inclinable at various angles. Each lamp has focusing optical system and filter absorbing ultraviolet radiation and produces pulsating radiation flow with pulse succession frequency 9.4-9.5 Hz and radiation power of at least 400 W. The lamp at the upright top is filled with Mg vapor, the lowest one is filled with Zn vapor only. Three lamps in the middle part are filled with a mixture of Mg and Zn, in Mg and Zn vapor proportion being equal to 3:1, 1:1, 1:3 in moving from upright top to down, respectively.
Method for applying surgical removal and photodynamic prophylaxis of recurrent subretinal neovascular membranes Method for applying surgical removal and photodynamic prophylaxis of recurrent subretinal neovascular membranes / 2243748
Method involves introducing 0.1-0.3 ml of photosensitizing gel preliminarily activated with laser radiation, after having removed neovascular membrane. The photosensitizing gel is based on a viscoelastic of hyaluronic acid containing khlorin, selected from group containing photolon, radachlorine or photoditazine in the amount of 0.1-2% by mass. The photosensitizing gel is in vitro activated with laser radiation having wavelength of 661-666 nm during 3-10 min with total radiation dose being equal to 100-600 J/cm2. The gel is introduced immediately after being activated. To compress the retina, vitreous cavity is filled with perfluororganic compound or air to be further substituted with silicon oil. The operation is ended with placing sutures on sclerotomy and conjunctiva areas. Compounds like chealon, viscoate or hyatulon are used as viscoelastic based on hyaluronic acid. Perfluormetylcyclohexylperidin, perfluortributylamine or perfluorpolyester or like are used as the perfluororganic compound for filling vitreous cavity.
Photodynamic surgical method for treating the cases of choroid hemangioma / 2243753
Method involves making incision in conjunctiva and Tenon's capsule of 3-4 mm in size in choroid hemangioma projection to sclera 3-4 mm far from limb. Tunnel is built between sclera and Tenon's capsule to extrasclerally introduce flexible polymer magnetolaser implant through the tunnel to the place, the choroid hemangioma is localized, after performing transscleral diaphanoscopic adjustment of choroid hemangioma localization and size, under visual control using guidance beam. The implant has permanent ring-shaped magnet in the center of which a short focus scattering lens of laser radiator is fixed. The lens is connected to light guide in soft flexible envelope. The permanent implant magnet is axially magnetized and produces permanent magnetic field of 2-3 mTesla units intensity. It is arranged with its north pole turned towards the choroid hemangioma so that extrascleral implant laser radiator disposition. The other end of the implant is sutured to sclera 5-6 mm far from the limb with two interrupted sutures through prefabricated openings. The implant is covered with conjunctiva and relaxation sutures are placed over it. Light guide outlet is attached to temple using any known method. 0.1-1% khlorin solution is injected in intravenous bolus dose of 0.8-1.1 mg/kg as photosensitizer and visual control of choroid hemangioma cells fluorescence and fluorescent diagnosis methods are applied. After saturating choroid hemangioma with the photosensitizer to maximum level, transscleral choroid hemangioma laser radiation treatment is carried out via laser light guide and implant lens using divergent laser radiation at wavelength of 661-666 nm with total radiation dose being equal to 30-120 J/cm2. The flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, samarium-iron-nitrogen or neodymium-iron-boron system material. The photosensitizer is repeatedly intravenously introduced at the same dose in 2-3 days after the first laser radiation treatment. Visual intraocular neoplasm cells fluorescence control is carried out using fluorescent diagnosis techniques. Maximum level of saturation with the photosensitizer being achieved in the intraocular neoplasm, repeated laser irradiation of the choroid hemangioma is carried out with radiation dose of 30-60 J/cm2.
Photodynamic surgical method for treating the cases of intraocular neoplasms Photodynamic surgical method for treating the cases of intraocular neoplasms / 2243754
Method involves creating tunnel between sclera and Tenon's capsule in intraocular neoplasm projection. Intraocular neoplasm localization and size is adjusted by applying transscleral diaphanoscopic examination method. 0.1-0.3 ml of photosensitizing gel based on viscoelastic of hyaluronic acid, selected from group containing chealon, viscoate or hyatulon, is transsclerally introduced into intraocular neoplasm structure using special purpose needle in dosed manner. The photosensitizing gel contains khlorin, selected from group containing photolon, radachlorine or photoditazine in the amount of 0.1-1% by mass. Flexible polymer magnetolaser implant is extrasclerally introduced into the built tunnel in intraocular neoplasm projection zone under visual control using guidance beam. The implant has permanent ring-shaped magnet axially magnetized and producing permanent magnetic field of 3-4 mTesla units intensity, in the center of which a short focus scattering lens of laser radiator is fixed. The lens is connected to light guide in soft flexible envelope. The implant is arranged with its north pole turned towards the intraocular neoplasm so that implant laser radiator lens is extrasclerally arranged in intraocular neoplasm projection zone. The implant light guide is sutured to sclera 5-6 mm far from the limb with single interrupted suture. The implant is covered with conjunctiva and relaxation sutures are placed over it. Light guide outlet is attached to temple using any known method. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, transscleral intraocular neoplasm laser radiation treatment is carried out via laser light guide and implant lens using divergent laser radiation at wavelength of 661-666 nm. The treatment course being over, the flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, neodymium-iron-boron or samarium-iron-nitrogen. 0.1-1% khlorin solution as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is additionally intravenously introduced in 2-3 days at a dose of 0.8-1.1 mg/kg and repeated laser irradiation of the intraocular neoplasm is carried out with radiation dose of 30-45 J/cm2 15-20 min later during 30-90 s.
Electrochemical destruction and photodynamic surgical method for treating the cases of intraocular neoplasms Electrochemical destruction and photodynamic surgical method for treating the cases of intraocular neoplasms / 2243755
Method involves applying transscleral diaphanoscopic examination method for adjusting intraocular neoplasm localization and size. Rectangular scleral pocket is built 2/3 times as large as sclera thickness which base is turned from the limb. Several electrodes manufactured from a metal of platinum group are introduced into intraocular neoplasm structure via the built scleral pocket. Next to it, intraocular neoplasm electrochemical destruction is carried out in changing electrodes polarity with current intensity of 100 mA during 1-10 min, and the electrodes are removed. Superficial scleral flap is returned to its place and fixed with interrupted sutures. 0.1-2% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, transpupillary laser radiation of 661-666 nm large wavelength is applied at a dose of 30-120 J/cm2. the operation is ended with placing sutures on conjunctiva. Platinum, iridium or rhodium are used as the metals of platinum group. The number of electrodes is equal to 4-8. 0.1-1% khlorin solution, selected from group containing photolon, radachlorine or photoditazine, is additionally repeatedly intravenously introduced in 2-3 days at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, repeated laser irradiation of the intraocular neoplasm is carried out with radiation dose of 30-45 J/cm2.
Method for treating relapses of uterine cervix cancer / 2243766
The present innovation deals with treating patients with uterine cervix cancer with relapses in parametral fiber and in case of no possibility for radical operative interference and effect of previous radiation therapy. During the 1st d of therapy one should intravenously inject 30 mg platidiam incubated for 1 h at 37 C with 150 ml autoblood, during the next 3 d comes external irradiation per 2.6 G-r. During the 5th d of therapy one should introduce the following composition into presacral space: 60 ml 0.5%-novocaine solution, 1 ml hydrocortisone suspension, 2 ml 50%-analgin solution, 1 ml 0.01%-vitamin B12 solution, 1.6 g gentamycine, 800 mg cyclophosphan, 10 mg metothrexate. These curative impacts should be repeated at mentioned sequence four times. The method enables to decrease radiation loading and toxic manifestations of anti-tumor therapy at achieving increased percent of tumor regression.
Method for treatment of uterus body topically spread cancer / 2243771
Invention relates to a method for treatment of uterus body topically spread cancer involving applying chemotherapy and intrauterus irradiation. Method is carried out by the following manner: at the 1-st day of treatment cyclophosphan is administrated in the dose 1200-1600 mg by interstitial paratumoral route; at the 2-d day cream-like based fluorouracil in the dose 300-550 mg or adriablastin in the dose 20-30 mg is administrated into uterus cavity; on the next day sйance of intracavitary irradiation is carried out in the dose 10 Gr. All these procedures are repeated three times with interval for 6 days. Method provides high topical concentrations of chemopreparations in tumor zone in reducing their adverse toxic effect that results to the curative effect of patients of elderly age with accompanying therapeutic diseases.
Method for treating the cases of caries with silver nitrate / 2243775
Method involves preparation dental surface, covering it with 30% aqueous solution of silver nitrate and recovery agent for precipitating insoluble silver salts. Silver salts precipitation is carried out by exposing silver nitrate covering tooth surface with halogen radiation of the kind produced by halogen lamp of 12 W or 75 W having spectral bandwidth of 400…500 nm provided with light guide for concentrating luminous flux for 60 s.
Method for treating vascular cutaneous neoplasms / 2243792
The present innovation deals with treating vascular cutaneous neoplasms, such as nevus flammeus and gemangiomas. Light-thermal impact at energy ranged 39-47 J/sq. cm should be performed in two stages, and between them, 2-3 wk after the onset of vascular resistance at the first stage one should perform beta-therapy daily for 2-3 d at single dosage being 20 g. Then, 3 wk later it is necessary to conduct the second stage of light-thermal impact by starting at energy value being 42 J/sq. cm, not less. The method enables to shorten therapy terms due to applying combined method to affect vascular cutaneous neoplasms.

FIELD: medicine.

SUBSTANCE: method involves using Hann diode crystal with proper frequencies of pathogenic microorganisms and cells during their death period or during the stimulating factors action period being applied.

EFFECT: enhanced effectiveness of treatment; wider range of biophysical action types.

3 cl, 1 tbl

 

The invention relates to information-wave medicine and medical technology and can be used in physiotherapy, reflexology and bioresonance therapy to regulate the functional activity of biological systems.

There is a method of treating a pathological state of the organism biologically active fluid (BAJ) using chemically and electrically neutral water, exposed to electromagnetic fields (special technique), by application of medical information individually selected test objects (VNIRO. Guide electropunctural diagnostics and drug-free treatment BAJ. - Alma-ATA, 1991. - p.27-37).

However, this method is not effective, due to the fact that the Belarusian Association of journalists as media unstable and requires sophisticated technology of storage and use.

There is a method of treatment of pathological conditions of the body by measuring biopotentials in biologically active points before and after removing the electromagnetic wave characteristics with matrix medical test objects, then determine using a controlled pulse laser frequency-wave parameters Meridian psyche with the transfer of information on solid media, which is used in its continuous contact influence on measures of the Dian psyche (Patent of the Republic of Kazakhstan No. 332, publ. 10.06.96).

However, this method has low effectiveness of physiotherapy in the treatment process due to the low specificity bioinformatics effects on the body.

There is a method of treatment of pathological conditions, including electro-acupuncture testing haloaliphatic drugs, natural vibrations of the body of the patient or their frequency-wave analogues followed by resonant transfer of information to the media with the possibility of changing the phase angle of 180°. As the carrier using a crystal diode Gunn. The transfer of information is carried out by feeding the supply voltage in direct contact with drugs and then off. After that, the Gunn diode is placed on biologically active points and zones of the body (Patent RF № 2141304, IPC And 61 N 39/00, publ. 20.11.99).

However, this method also has a low effectiveness of physiotherapy in the treatment process due to the low specificity bioinformatics effects on the body.

The closest technical solution (prototype) is the way bioinformatics effect on microorganisms, including medical record wave of information about their own variations of the microorganism and information about Romeo and allopathic medicines nancial, made in the form of a crystal diode Gunn, and its subsequent placement on biologically active points and zones of the body. Crystal Gunn diode is made in the form of a structure with separated working volumes and record information about each drug is carried out on the respective working volume of the crystal diode Gunn by feeding the supply voltage to the working volume by direct contact of the crystal with the drug and its subsequent off (Patent RF № 2155083, IPC And 61 N 5/00, publ. 27.08.2000).

However, this method also has a low effectiveness of physiotherapy in the treatment process due to the low specificity bioinformatics effects on the body.

The technical result of the invention is to increase the specificity of bioinformatics effects on the body due to the use as a therapeutic wave information the information recorded on the media in the process of destruction of pathogenic microorganisms, or viruses, or tumor cells, or the information recorded on the media in the process of intensive growth of beneficial autochthonous microflora.

This technical result is achieved in that in the method of bioinformatics effect on microorganisms, or viruses, or tumor cells, including medical record wave information from the containing a series of information about one's own electromagnetic oscillations of the microorganism, or virus, or tumor cells, and wave information from an object with therapeutic properties, to the media, made in the form of a crystal diode Gunn, by feeding the supply voltage to the working volume of the crystal diode in direct contact with the microorganism or virus, or tumor cells, or an object with therapeutic properties, and then off, and place the crystal on biologically active points and zones of the body, according to the invention as an object with therapeutic properties, use their own variations of pathogenic microorganism or virus, or tumor cells in the period of their death when exposed to any abscopal factors or vibrations autochthonous microorganisms in the period of exposure to favorable incentives, providing intensive development and reproduction of autochthonous microorganisms in the logarithmic growth phase. As an adverse factor causing the death of a pathogenic microorganism or virus, or tumor cells, use of antibiotics, or sterilizing agents, or exposure to heat or ultraviolet or radiation exposure.

As appropriate enabling factors for intensive development and reproduction auto is ton of microorganisms in the logarithmic growth phase, are bifidogenic, lactogenic, growth factors, vitamins and trace elements.

The recording time of healing wave information from the object, with a therapeutic effect on the media is 10-40 minutes.

The method is as follows. First by electro-acupuncture diagnostics electrical condition of biologically active points of the body of the patient, for example, the device type "Medeo" before and after drug test objects that have medicinal properties, and natural vibrations of the body.

For implementing the method using a portable handheld device with a set of emitters is extremely high purity (EHF) frequency range (42,2-100,0) GHz for EHF-therapy of type "Stella" with media set-color resonant microwave information (crystal Gunn diode), developed by the inventor A.M. Andriy Kozhemiakin and protected by the RF patent № 2141304, IPC And 61 N 39/00, publ. 20.11.99. The medium contains a polymer insulating sheath, a Gunn diode, made in the form of a semiconductor crystal with metal contacts and the conductors of supply.

For use in therapeutic purposes write on crystal healing wave information, containing information about their own variations of the patient's body, on its own fluctuations of the microorganism, VIR is sa or tumor cells, as well as information about their own variations of these objects during their death when exposed to inhibitory factors or information about their own vibrations autochthonous microorganisms of the patient during the period of exposure to favorable incentives, providing intensive development and reproduction of autochthonous microorganisms in the logarithmic growth phase. Device (media) placed near a source of healing wave information on the Gunn diode through the conductors serves the supply voltage specified in the passport (3 volts). This changes quantummechanically parameters of the crystalline structure of the diode and to the emission of electromagnetic energy in the microwave range. The radiated wave from the diode goes to the object, with medicinal properties, modulates its own oscillations, paratragedy and comes to the diode. When switching off the supply voltage of the diode its crystal structure is returned in the original quantummechanical state, which is influenced by healing wave information received by the crystal with the reflected electromagnetic wave, and the media (Gunn diode) is ready to use. Further work is media based on the conversion of the energy of thermal vibrations of the crystal d is etki semiconductor and external fields in the low-intensity energy wave radiation, where as a part of the present therapeutic vibrations, and the device is without a supply of external power. To eliminate interference with the recorded parameters must submit to the supply voltage. Overwrite healing wave information can be done multiple times.

To ensure the patient's crystal Gunn diode is placed in a biologically active points and zones of his body, fixed media, for example, patch, where it has a long contact therapeutic effect on the body.

Below are examples (1-5) preparation of media, with medicinal properties, and experimental studies bioinformatics impact on biological objects.

Example 1. The way bioinformatics impact on the human immunodeficiency virus

Experimental studies show that ethanol at a concentration of 5%, 2.5% and 1.25% of no toxic effects on human cells, in particular cells MT-4, but significantly inhibit the infectious activity of the human immunodeficiency virus.

The studies were conducted in HIV-1 strain by incubating equal volumes of non-toxic final concentration of 5%ethanol (inhibitory factor) and the initial concentration vaccinated suspension of HIV-1 at room themes is the temperature value for at least 30 minutes. After 10 minutes near investigated (containing ethanol) and control (does not contain ethanol) samples of vaccinated place liquid capsules with native speakers, made in the form of a Gunn diode, connected to the apparatus type “Stella”, and incubated for 10-20 minutes.

The media with the recorded medical information used in the following way. Prepared samples of HIV-containing suspension, part of which was processed by placing around them capsules with native medical information about the death of HIV infection in 12-24 hours. Control samples from vaccinated suspension is not subjected to bioinformatics impact.

After that prepare a tenfold dilution vaccinated suspension study and control samples in culture medium RPMI-1640 with the addition of 10% serum fetal cow, 2 mm L-glutamine, 100 μg/ml kanamycin, 160 μg/ml gentamicin, making permissively lymphoblastoid cell culture human MT-4, scattered in 96-well culture tablets company "Costar" in a volume of 200 µl with a concentration of 1 million cells/ml Cell suspension incubated at 37 ° C in a humid atmosphere (95%) with 5% CO2and titration of infectivity of HIV-1 in culture human lymphoblastoid cells MT-4. Monitoring is conducted daily what UPE by microscopy of wells under an inverted microscope (Diavert" registration process of cluster formation, the viability of cells and preparation of slides of cells on a slide glass with non-fatty determine the number of infected cells MT-4 in the reaction of indirect immunofluorescence assay (NIF). Smears of cells after drying locks in the solution chilled to minus 20 degrees With acetone for 12 hours and Then process them working dilutions of sera containing specific antibodies to HIV-1 (1:100) and control for 30 min in a humid chamber at a temperature of 37 ° C. then washed three times in saline solution and dyed rabbit antibodies against human immunoglobulins labeled with FITZ, in a dilution of 1:32 for 20 min in a humid chamber at a temperature of 37 degrees C. At the final stage strokes twice washed with buffered saline solution and rinsed with distilled water after which spend their microscopy, the fluorescent microscope (Axioskop" firm Opton (Germany), determining the percentage of HIV-1-infected cells MT-4 and the intensity of the fluorescent glow of infected cells.

At 12-24 hour bioinformatics processing samples of HIV-containing cell suspension MT-4 medical information on the death of the virus, recorded on a carrier, there is a significant change in the infectious properties of the virus, because the clustering of infection is different cells MT-4 was maintained in all the tested dilutions of the virus at the level of uninfected control cells. In used doses of medical information completely inhibits the infectivity of HIV-1 to 2 lg. This significantly decreases the intensity of the fluorescent glow of infected cells MT-4, and hence the degree of reproduction of human immunodeficiency virus 1 type in them. In the control samples infectious activity of HIV-1 is preserved.

Example 2. The way a bioinformatics effect on tumor cells of Ehrlich adenocarcinoma

For the experiment, prepare tubes with samples of cell suspension transplantable tumors adenocarcinoma Ehrlich in the amount of 20 ml each. Some of the specimens are placed in an incubator with a temperature of 42.5° (inhibitory factor) and incubated at the same temperature for 50 minutes. 15 minutes after the start of the experiment in a test tube is placed in the capsule with the media, made in the form of a Gunn diode, connected to the apparatus type “Stella”, which is recording information about the death of tumor cells. After 50 minutes, the tubes are removed from thermostat. Next part of the test tubes with a suspension of tumor cells that were not exposed to heat, place the capsule with the recorded medical information about cell death transplantable tumors adenocarcinoma Ehrlich and maintain them within 24 hours.

Further experiments about the W ill result in outbred ICR mice, the males weighing 25-30 g, which transplantation of the patient subcutaneously in the region of the armpit at a dose of 105 tumor cells in an animal: one group was injected control untreated suspension of tumor cells; the second group - the suspension of tumor cells treated at a temperature of 42.5°and the third group of mice - a suspension of tumor cells subjected to bioinformatics effect within 24 hours. After a few days in the first group of mice showed marked growth of tumor tissue, and the second and third group within 10 days of the observation of the formation and growth of tumor tissue was not found.

Then took the first group of mice with a distinct adenocarcinoma Ehrlich and each mouse daily during the week, recorded on the area of the tumor capsule from the carrier medical information about the death of tumor cells. After a 7-day bioinformatics effects in 100% of mice observed marked growth inhibition of the tumor site.

Example 3. The way bioinformatics impact on vegetative forms of bacteria

To obtain vegetative forms of bacteria take several samples of 1 g dry preparation of Bacillus subtilis type “Baktisubtil” in spore form, each dissolved in 10 ml of saline solution at a temperature of 85°C and maintained at this temperature for 30 minutes. While str is a new form of bacteria enters the vegetative. Then 1 ml suspension of bacteria are placed in Petri dishes on the surface of the agar with mesopartner broth and incubated for 36 hours in a thermostat at a temperature of 37°C. Then loop these bacteria in the vegetative form is transferred into several test tubes with mesopartner broth, which is injected in 2 ml of penicillin activity of 1,000,000 UNITS (inhibitory factor), stirred and placed in a thermostat at a temperature of 37°C. After 10 minutes in a test tube with bacteria enter a sterile set of capsules with native speakers, made in the form of a Gunn diode, connected to the device type “Stella”, which is a record of medical information on the death of the bacteria in the vegetative form. Capsules information removed from the tubes through 10-20 minutes.

For experimental validation of bioinformatic the effects of media on bacterial vegetative cells form the control and test samples. To do this, take 1 ml suspension of bacteria in Bacillus subtilis vegetative form and placed in Petri dishes on the surface of the agar with mesopartner broth and incubated for 36 hours in a thermostat at a temperature of 37°C. near the investigated samples are placed in the capsule with the media about the death of bacteria in the vegetative form. Analysis of samples after incubation shows that in control samples observed the Xia active growth of bacterial colonies and in the test - delay their growth.

Example 4. The way bioinformatics impact on spore forms of bacteria

Take several samples of 1 g dry preparation of Bacillus subtilis type “Baktisubtil” in spore form, each dissolved in 10 ml of 1%formalin solution at a temperature of 70-85°C and maintained at this temperature for 50 minutes. 20 minutes after the start of the next experiment with the samples placed or injected into the tubes with bacteria sterile capsules with native speakers, made in the form of a Gunn diode, connected to the apparatus type “Stella”, which is a record of medical information on the death of the bacteria in spore form. Capsules information sequentially removed from the test tubes 15-30 minutes.

Next, take the tubes with disputes 1 g dry preparation of Bacillus subtilis. Some of them leave as a control, and in the other place the capsules with the media about the death of bacteria in spore form and maintain them within 12-24 hours at room temperature. Then in a test tube with the control and intervention samples injected 10 ml of saline solution with a temperature of 85°C and maintained at this temperature for 30 minutes. When this spore form of the bacteria enters the vegetative. Then 1 ml suspension of bacteria from each tube was placed in Petri dishes on the surface of the agar with meats is peptone broth and incubated for 36 hours in a thermostat at a temperature of 37° C.

Analysis of samples after incubation shows that in the control samples, there is active growth of colonies of bacteria, and in the test - delay their growth.

Example 5. The way bioinformatics effects on autochthonous microflora of mammals

First, take samples of faeces from a group of laboratory rabbits participating in the experiment. The investigated material is titrated with a sterile saline solution, making serially tenfold diluted to 108. From different breeding specified material inoculated on nutrient medium, Blaurock, aloes, Endo, Viburnum, Mrs-4, blood agar with polymyxin to determine the baseline levels of coliform bacteria, lactobacilli, bifidobacteria, enterococci, staphylococci and other bacteria with subsequent identification and selection of autostartup normal intestinal microflora containing bifidobacteria and lactobacilli, coliforms, lactic acid streptococci, lactobacilli bacteria. Two days later material, for example, from isolated colonies of lactobacilli grown in the medium Mrs-4, isolated from colonies of bacteria growing on the environment Blaurock from isolated colonies of enterococci, e.g. Streptococcus faecium, grown on medium Kalina, from isolated colonies of Escherichia coli (E. coli)grown on blood agar with polymyxin, t see you a again is subcultured onto appropriate selective medium. Grew up two days after the second passage of the isolated colonies of bifidobacteria and lactobacilli, enterococci, Escherichia coli subcultured (separately) by the above nutrient medium, Blaurock, Mrs-4, Kalina, blood agar with polymyxin and cultured by standard methods to obtain the biomass of microorganisms. For example, the biomass of bifidobacteria has a titer of not less than 109 cells/ml, biomass lactobacilli - 109-1010 cells/ml, biomass Escherichia coli - not less than 107-CL/ml, and biomass Streptococcus faecium is not less than 109 cells/ml Then the biomass of each species autochthonous strains of microorganisms administered in equal ratio to the reactor and stirred to obtain a mixture of bacteria. As the mixture is injected differentiated nutrient medium on the basis of, for example, corn hydrolysate with added stimulating bifidogenic, lactogenic and growth factors: insulin, sodium Selenite, vitamins, amino acids and cultivated biomass at a temperature of 37°C to logarithmic phase of growth (no more than 4-5 hours). Next to the reactor enter a sterile set of capsules with native speakers, made in the form of a Gunn diode, connected to the apparatus type “Stella”, which is recording information about the intensive growth and development of the autochthonous microflora. Capsules incubated for 15-30 minutes, turn off the device “Stella” and Animat from the reactor.

Then the rabbits injected with antibiotics for 10 days to obtain explicit dysbacteriosis. Next, rabbits divided into three groups. The first is a control group, which only provide the food. The second group treatment probiotics such as bifidobakterii and colibacterin, which is introduced into animal feed, for 10 days. The third group of animals is attached in the region of the gastrointestinal tract (in different departments) capsules with native bio-information about the intensive growth and development of their autochthonous microflora, which are not removed within 7 days.

Table 1
Bacteriological studies of the intestinal microflora rabbits after treatment
The name of the microorganisms The number of microbes in 1 g of feces of mice
The 1st group (control) 2nd group of rabbits after treatment with probiotics Group 3 rabbits after a bioinformatics impact
1. Lactobacillus 105 108 108-1010
2. Bifidobacterium 105 109 108-1010
3. Bacteroides 105-106 106 -108 108-1010
4. Escherichia (lac+) 105-106 105-108 109
5. Escherichia (Lac-) 105-106 105-106 -
6. Escherichia (laborer.) 105-106 105-106 -
7.Escherichia(Gamal.) 105-106 105-107 -
8. Enterococcus 105 105-lO7 105-109
9. Staphlococcus 105-106 - -
10. Proteus 105-106 - -
11. Clostridium 105-106 102 -
12. Fungi Candida 105-108 103-104 -

Bacteriological studies fekalii three groups of rabbits was conducted in accordance with guidelines of "Dysbiosis and methods of laboratory diagnostics", which showed that treatment with probiotics and bioinformatics impact on ICRI the flora of animals was not only a significant reduction in the level of pathogenic and conditionally pathogenic microflora, but the increase in bifidobacteria and lactobacilli almost equally from 105 to 108-1010 microbial cells in 1 g of feces (table 1), the displacement of some of conditionally pathogenic microorganisms.

Thus, the present invention can be used for the treatment of pathological conditions caused by various pathogenic microorganisms, viruses, and prophylaxis and treatment of oncological diseases and dysbacteriosis with high specificity without the use of drugs or greatly reduce their dose and side effects.

1. The method of wave action on pathogenic microorganisms, viruses or tumor cells in the experiment using a crystal diode Gunn by feeding the supply voltage to the working volume of the crystal with prior contact with such a microorganism or virus, or tumor cells with subsequent disconnection of the crystal and placing it on biologically active points and zones of a mammal, characterized in that prior contact with crystal use their own variations of pathogenic microorganism or virus, or tumor cells in the period of mass death when exposed to inhibitory factor or vibrations autochthonous microorganisms of the mammal during the period of exposure to BL is favourable stimulating factor, providing intensive development and reproduction of autochthonous microorganisms in the logarithmic growth phase.

2. The method according to claim 1, characterized in that as an inhibitory factor used antibiotics, or sterilizing agents, or exposure to heat or ultraviolet or radiation exposure.

3. The method according to claim 1, characterized in that as a favorable stimulating factor, providing intensive development and reproduction of autochthonous microorganisms in the logarithmic growth phase, use bifidogenic, lactogenic growth factors, vitamins and trace elements.

 

© 2013-2014 Russian business network RussianPatents.com - Special Russian commercial information project for world wide. Foreign filing in English.